Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA
暂无分享,去创建一个
R. Barriales-Villa | J. P. Ochoa | José M. Larrañaga-Moreira | Joel Salazar-Mendiguchía | Carles Díez-López | María Alejandra Restrepo-Córdoba | Jorge Álvarez-Rubio | Ainhoa Robles-Mezcua | María C. Olmo-Conesa | Elisa Nicolás-Rocamora | J. Sanz | Eduardo Villacorta | María Gallego-Delgado | Raquel Yotti | M. Espinosa | A. J. Manovel | Luis M. Rincón-Díaz | Juan Jiménez-Jáimez | F. Bermúdez-Jiménez | M. T. Basurte-Elorz | Vicente E. Climent-Payá | María I. García-Álvarez | J. Rodríguez-Palomares | Javier Limeres-Freire | A. Pérez-Guerrero | Eva-María Cantero-Pérez | María-Luisa Peña-Peña | Julián Palomino-Doza | M. G. Crespo-Leiro | J. M. García-Pinilla | Esther Zorio | Tomás Ripoll-Vera | P. García-Pavía | Martin Ortiz-Genga | L. Monserrat | C. Díez-López | J. M. García-Pinilla | R. Yotti | Pablo García-Pavía | Ainhoa Pérez-Guerrero | María G. Crespo-Leiro | E. Zorio | J. P. Ochoa | María C. Olmo-Conesa | María Angeles Espinosa | Luis M. Rincón-Díaz | M. Teresa Basurte-Elorz | María I. García-Álvarez | José Fernando Rodríguez-Palomares | J. M. Larrañaga-Moreira
[1] J. Ochoa,et al. Letter by Barriales-Villa et al Regarding Article, "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies". , 2019, Circulation.
[2] R. Porcher,et al. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. , 2019, Circulation.
[3] E. Arbustini,et al. Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature , 2018, Open Heart.
[4] E. Arbustini,et al. Lamin missense mutations—the spectrum of phenotype variability is increasing , 2018, European journal of heart failure.
[5] Y. Pinto,et al. The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope , 2018, European journal of heart failure.
[6] William J. Bryant,et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Heart rhythm.
[7] A. Wilde,et al. Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation , 2017, Circulation. Cardiovascular genetics.
[8] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[9] A. Zwinderman,et al. Gender‐specific differences in major cardiac events and mortality in lamin A/C mutation carriers , 2013, European journal of heart failure.
[10] A. Zwinderman,et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.
[11] I. V. Van Gelder,et al. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. , 2007, American heart journal.
[12] Y. Pinto,et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.
[13] L. Mestroni,et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. , 2003, Journal of the American College of Cardiology.
[14] Eloisa Arbustini,et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. , 2002, Journal of the American College of Cardiology.
[15] William J. Bryant,et al. Practice Guideline: Executive Summary2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2017 .
[16] H. Crijns,et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.